NCT01521364View on ClinicalTrials.gov

Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

November 30, 2012

Conditions
Multidrug-resistant TuberculosisExtensively Drug-resistant Tuberculosis
Interventions
DRUG

Addition of different doses of clarithromycin.

"At week 1, 250mg clarithromycin once a day will be added to linezolid therapy during two weeks.~At week 3, 500mg clarithromycin once a day will be added to linezolid therapy during to weeks."

Trial Locations (1)

Unknown

Tuberculosis Center Beatrixoord, Haren

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT01521364 - Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients | Biotech Hunter | Biotech Hunter